FAKTOR-OPTIONSSCHEIN - AB SCIENCE Share Price

DE000MA5WZ99

Delayed Börse Stuttgart 09:44:01 28/05/2024 BST
0.022 ^EUR	-18.52%

3 months	-12.00%
6 months	-72.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AB SCIENCE

Latest news about AB SCIENCE

AB Science reports its revenues for the year 2023 and provides an update on its activities	05-15	GL
AB Science: European patent granted for masitinib	05-13	CF
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036	05-13	GL
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient	05-07	GL

More news

Quotes 5-day view

Date	Price	Change
28/05/24	0.022	-18.52%
27/05/24	0.027	+8.00%
24/05/24	0.025	0.00%
23/05/24	0.025	0.00%
22/05/24	0.025	-3.85%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 09:44 am

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	AB SCIENCE
Issuer	Morgan Stanley
WKN	MA5WZ9
ISIN	DE000MA5WZ99
Date issued	26/03/2021
Strike	0.9862 €
Maturity	Unlimited
Parity	43.21 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	13.22 €
Lowest since issue	0.015 €

Company Profile

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Sector

More about the company

Consensus: AB Science

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.972 EUR

Average target price

6.895 EUR

Spread / Average Target

+249.65%

Consensus